The Thrombectomy Devices Market size in the Middle East & Africa was worth USD 0.116 billion in 2023 It is expected to reach USD 0.151 billion by 2028, growing at a CAGR of 5.49% from 2023 to 2028.
Thrombectomy Devices can be defined as emergency removal of thrombi by surgical procedures, leading to blocked blood circulation. Thrombi are actually blood clots, but in common usage, it can refer to any material that blocks blood flow and can lead to health problems. Generally, the last resort as a hindrance of blood flow to organs for a long time can lead to necrosis.
Generally, the most used surgical procedures are surgical embolectomy, balloon embolectomy, and aspiration embolectomy. Surgical embolectomy clot removal by surgical incision into an artery. Aspiration embolectomy involves thrombus removal by using suction instead of a balloon. It is considered an effective way for thrombi removal in limb arteries. In balloon embolectomy, the catheter is inserted into a blood vessel, which has an inflatable balloon at the tip, inflated after its insertion into a clot. Then the balloon is removed along with the clot. This procedure involves risk since there is a chance of intimal lesions, giving rise to another thrombosis.
The driving factors of the Middle East and Africa Thrombectomy Devices market are increasing demand for minimally invasive procedures, technological innovations in the medical field, growing geriatric population, rising prevalence of cardiovascular diseases, and growing sedentary lifestyle. However, the market is constrained by factors like lack of awareness about peripheral vascular diseases, difficulty using new equipment, and lack of skilled workers.
This research report on the Middle East and Africa Thrombectomy Devices Market has been segmented and sub-segmented into the following categories:
By End Users:
Geographically, the market is still in its nascent stages in the region. Factors such as rising technological innovations in the medical field, rising geriatric population, and increased incidence of cardiovascular diseases are expected to drive the market growth in the region.
Companies operating in the MEA Thrombectomy Devices Market Profiled in the Report are Stryker Corporation (U.S.), Medtronic Plc (U.S.), Boston Scientific Corporation (U.S.), Penumbra, Inc. (U.S.) Johnson & Johnson (U.S.), Terumo Corporation (Japan), Spectranetics Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Argon Medical Devices, Inc. (U.S.), and Teleflex Incorporated (U.S.).
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]